Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting Biomatrices

Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”)  announced a change of the Company’s name to Elutia Inc. The rebranding reflects the ...

September 07, 2023 | Thursday | News
Twist Bioscience and Ono Pharmaceutical Collaborate on Autoimmune Antibodies

“Ono has a strong and proven track record in developing antibody candidates in areas of need, including the development of the anti-PD-1 antibody Opd...

September 01, 2023 | Friday | News
23andMe Granted New FDA Clearance to Report Additional BRCA Variants

510(k) clearance will allow 23andMe to report an additional 41 genetic variants in the BRCA1 and BRCA2 genes that increase risk for breast, ovarian, prosta...

September 01, 2023 | Friday | News
Catalent Announces Governance Enhancements and New Initiatives to Drive Value

Adding Four New Independent Directors Appoints John Greisch as Executive Chair Establishes New Strategic and Operational Review Committee of the Board ...

August 30, 2023 | Wednesday | News
ImmunoGen Teams Up with Takeda to Bring ELAHERE® to Japanese Market

ImmunoGen to Receive $34 Million1 in Upfront and Near-Term Milestone Payments and is Eligible to Receive Potential Regulatory and Commercial Milestone Paym...

August 29, 2023 | Tuesday | News
Twist Bioscience Releases 2023 ESG Report and Quantifies Carbon Footprint of Manufacturing a Single Gene

“We took a big step forward in our ongoing commitment to deliver sustainable solutions to our customers, quantifying the impact of our proprietary ap...

August 23, 2023 | Wednesday | Reports
LEO Pharma Signs Agreement to Acquire Timber Pharmaceuticals

The deal represents a total transaction value of up to $36 million with (i) an initial upfront consideration of $14 million, and (ii) up to an additional $...

August 22, 2023 | Tuesday | News
Study Explores Masimo PVi® for Targeted Liquid Therapy in Elderly Surgical Patients

Researchers found that fluid therapy guided by non-invasive and continuous PVi can reduce cardiopulmonary complications and infusion.   Masimo (NASD...

August 22, 2023 | Tuesday | News
AGC Biologics Partners with Asahi Kasei Pharma Corporation on Clinical Antibody Project

Under the agreement, AGC Biologics will leverage its monoclonal antibody development and manufacturing experience to perform process transfer, process opti...

August 17, 2023 | Thursday | News
TAE Life Sciences Partners with Biddle Sawyer for Cancer Treatment Drug

TAE Life Sciences has  announced a landmark agreement with Biddle Sawyer to serve as the exclusive supplier of TC220, a novel boronated amino aci...

August 16, 2023 | Wednesday | News
MediWound Announces Collaboration with Mölnlycke on EscharEx® Phase III Study

MediWound Ltd. (Nasdaq: MDWD), a fully integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today anno...

August 16, 2023 | Wednesday | News
Hong Kong Department of Health has Approved the Registration Applications for the Uro-G and Uro-V Disposable Cystoscopic System

Uro-G offers a viewing angle of 120°, both 210° upward and 130° downward motion angles, and a 90° angle of rotation clockwise and countercl...

August 15, 2023 | Tuesday | News
Pfizer's ELREXFIO™ Granted U.S. FDA Accelerated Approval for Refractory Multiple Myeloma

The approval of ELREXFIO (elranatamab-bcmm) is based on clinically meaningful response rates and duration of response from Phase 2 MagnetisMM-3 study EL...

August 15, 2023 | Tuesday | News
Bristol Myers Squibb Joins Billion Dollar Roundtable, Boosts Supplier Diversity

- Achieves $1 billion investment goal with diverse-owned suppliers Expanding diverse-owned supplier spend globally to increase impact BMS established...

August 11, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close